Corporate Governance and Social Responsibility

The Board of Directors supports the principles of corporate governance advocated by The Principles of Good Governance and Code of Best Practice (2003) (“The Combined Code”) issued by the Financial Services Authority. The Company has applied the principles of the Combined Code, on a voluntary basis, that it considers appropriate. Full details are available in our Annual Report and Accounts.

The following information is provided pursuant to AIM Rule 26:

The Board

  • Biofusion is managed by a board of directors who meet regularly
  • Each board member receives monthly management accounts
  • The Company Secretary is responsible for ensuring that procedures, applicable rules and regulations are followed
  • The Board retains overall responsibility for the Company while day to day management is conducted by the executive directors
  • All directors are required to submit themselves for re-election by the shareholders at the Annual General Meeting at least every three years

Audit Committee

  • The Audit Committee comprises Doug Liversidge, Tony Atkinson and Edwin Moses
  • The Audit Committee examines and reviews internal controls, accounting policies and practices, the form and context of financial reports and statements
  • It makes recommendations to the Board regarding the performance of the auditors
  • Biofusion’s auditors and Chief Executive attend by invitation

Remuneration Committee

  • The Remuneration Committee comprises Doug Liversidge, Tony Atkinson and Edwin Moses
  • The Company’s policy on executive remuneration and details of executive directors’ individual remuneration packages are fixed by the committee or the Board and set out in the Annual Report and Accounts

Nomination Committee

  • The Nomination Committee comprises the non executive directors and the Chairman, Doug Liversidge.
  • It considers the appointment of both executive and non-executive directors

Articles of Association

Recent Circulars and Admission Document 

AIM Securities in Issue

  • As at 23 April 2008 36,663,967 shares were in issue
  • 89.03% of the shares are not in public hands
  • Major shareholders